ArticlePloS one2018
Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACTSEC model.
Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Costs and Healthcare Utilization of Heart Disease by COVID-19 Diagnosis and Race and Ethnicity.AJPM focus · 2025Article
- Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia.Archives of medical science : AMS · 2025Article
- Success in achieving LDL-C target values in a high-risk population in Slovakia: the SlovakLipid retrospective study.Archives of medical science : AMS · 2025Article
- Disparities in cardiovascular disease and treatment in the Nordic countries.The Lancet regional health. Europe · 2023Review
- Epidemiology of cardiovascular disease in Europe.Nature reviews. Cardiology · 2022Review
- Article
- Article
- Non-Persistence with Medication as a Mediator for the Social Inequality in Risk of Major Adverse Cardiovascular Events in Patients with Incident Acute Coronary Syndrome: A Nationwide Cohort Study.Clinical epidemiology · 2021Article
- Living with heart failure: perspectives of ethnic minority families.Open heart · 2020Article
- Assessment of Equity in Access to Percutaneous Coronary Intervention (PCI) Centres in Poland.Healthcare (Basel, Switzerland) · 2020Article
- Progress in reducing inequalities in cardiovascular disease mortality in Europe.Heart (British Cardiac Society) · 2020Article
- Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012.PloS one · 2020Article
- Social Factors, Sex, and Mortality Risk After Coronary Artery Bypass Grafting: A Population-Based Cohort Study.Journal of the American Heart Association · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo quantify the contribution of changes in different risk factors population levels and treatment uptake on the decline in CHD mortality in Denmark from 1991 to 2007 in different socioeconomic groups.
designWe used IMPACTSEC, a previously validated policy model using data from different population registries.
participantsAll adults aged 25-84 years living in Denmark in 1991 and 2007.
main outcome measureDeaths prevented or postponed (DPP).
resultsThere were approximately 11,000 fewer CHD deaths in Denmark in 2007 than would be expected if the 1991 mortality rates had persisted. Higher mortality rates were observed in the lowest socioeconomic quintile. The highest absolute reduction in CHD mortality was seen in this group but the highest relative reduction was in the most affluent socioeconomic quintile. Overall, the IMPACTSEC model explained nearly two thirds of the decline in. Improved treatments accounted for approximately 25% with the least relative mortality reduction in the most deprived quintile. Risk factor improvements accounted for approximately 40% of the mortality decrease with similar gains across all socio-economic groups. The 36% gap in explaining all DPPs may reflect inaccurate data or risk factors not quantified in the current model.
conclusionsAccording to the IMPACTSEC model, the largest contribution to the CHD mortality decline in Denmark from 1991 to 2007 was from improvements in risk factors, with similar gains across all socio-economic groups. However, we found a clear socioeconomic trend for the treatment contribution favouring the most affluent groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.